Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
- Gold slips after Bernanke hints at slowing bond buys
- FBI says man shot dead while being questioned about Boston bombings
- British soldier hacked to death in suspected Islamist attack
- Soldier hacked to death in London in suspected Islamist attack
- Short story writer Lydia Davis wins Man Booker International fiction prize
REUTERS SHOWCASE
Tax Avoidance
EU leaders talk tough on tackling Amazon, Google over taxes. Full Article | Related Story
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
MARKET EYE-India's Idea shares fall after Q3 earnings disappoint
* Shares in Idea Cellular Ltd shares fall as much as 2.6 percent after the mobile phone carrier posted weaker-than-expected October-December net profit. * Morgan Stanley says it could lower EBITDA estimates for Idea in fiscal 2013 by around 4 percent. * The investment bank adds Bharti Airtel Ltd could also miss EBITDA estimates for the October-December quarter. * Shares in Idea Cellular fall 0.5 percent, while Bharti Airtel shares fall 0.6 percent (manoj.dharra@thomsonreuters.com; manoj.dharra.thomsonreuters.com@reuters.net)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints






Follow Reuters